Conferences and Meetings114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I
114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I
114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I
0 activities
A Longitudinal Review Comparing Absolute Neutrophil Counts of Children with Sickle Cell Disease with and without the Duffy Null Phenotype
1 activities
A Longitudinal Review Comparing Absolute Neutrophil Counts of Children with Sickle Cell Disease with and without the Duffy Null Phenotype
A Phase 1 Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects with Stable Sickle Cell Disease: Trial in Progress
1 activities
A Phase 1 Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects with Stable Sickle Cell Disease: Trial in Progress
Adding CD117 Antibody to Alemtuzumab, Low Dose Total Body Irradiation (TBI), and Sirolimus for Matched Related Donor (MRD) Hematopoietic Cell Transplant (HCT) in Sickle Cell Disease (SCD): Initial Results
1 activities
Adding CD117 Antibody to Alemtuzumab, Low Dose Total Body Irradiation (TBI), and Sirolimus for Matched Related Donor (MRD) Hematopoietic Cell Transplant (HCT) in Sickle Cell Disease (SCD): Initial Results
Analysis of the Pilot Study of the International Hemoglobinopathy Research Network (INHERENT)
1 activities
Analysis of the Pilot Study of the International Hemoglobinopathy Research Network (INHERENT)
Autoimmune and Inflammatory Diseases in Children with Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues
1 activities
Autoimmune and Inflammatory Diseases in Children with Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues
Characterizing People with Sickle Cell Disease Who Share Attitudes Regarding Clinical Trial Participation: Findings from the Global LISTEN Survey
1 activities
Characterizing People with Sickle Cell Disease Who Share Attitudes Regarding Clinical Trial Participation: Findings from the Global LISTEN Survey
Data Driven Research through the European RADeep Registry and the Use of Artificial Intelligence Towards Personalized Medicine in Sickle Cell Disease
1 activities
Data Driven Research through the European RADeep Registry and the Use of Artificial Intelligence Towards Personalized Medicine in Sickle Cell Disease
Differences in the in-Hospital Outcomes of Sickle Cell Crisis Among Patients with and without Liver Cirrhosis: A Nationwide in-Patient Analysis
1 activities
Differences in the in-Hospital Outcomes of Sickle Cell Crisis Among Patients with and without Liver Cirrhosis: A Nationwide in-Patient Analysis
First-Year Outcomes of Newborn Sickle Cell Disease Screening in an Angolan Hospital
1 activities
First-Year Outcomes of Newborn Sickle Cell Disease Screening in an Angolan Hospital
How People with Sickle Cell Disease Rate Motivators is Associated with the Likelihood of Wanting to Participate in a Clinical Trial: Findings from the Global LISTEN Survey
1 activities
How People with Sickle Cell Disease Rate Motivators is Associated with the Likelihood of Wanting to Participate in a Clinical Trial: Findings from the Global LISTEN Survey
How to Lose an App in 10 Days: Exploring Digital Health Engagement in Sickle Cell Disease
1 activities
How to Lose an App in 10 Days: Exploring Digital Health Engagement in Sickle Cell Disease
Identification of Clinical Sub-Phenotypes of Sickle Cell Disease Using Latent Class Analysis
1 activities
Identification of Clinical Sub-Phenotypes of Sickle Cell Disease Using Latent Class Analysis
Impact of Duffy-Null Phenotype on Neutrophil Counts and Clinical Outcomes in Patients with Sickle Cell Disease and without Hydroxyurea
1 activities
Impact of Duffy-Null Phenotype on Neutrophil Counts and Clinical Outcomes in Patients with Sickle Cell Disease and without Hydroxyurea
Large Scale Analysis of the Real-World Association between Fetal Hemoglobin and Vaso-Occlusive Crises in Sickle Cell Disease
1 activities
Large Scale Analysis of the Real-World Association between Fetal Hemoglobin and Vaso-Occlusive Crises in Sickle Cell Disease
Maternal and Fetal Outcomes in Sickle Cell Disease: Single Center Review
1 activities
Maternal and Fetal Outcomes in Sickle Cell Disease: Single Center Review
Motivators and Barriers for People with Sickle Cell Disease Participating in Clinical Trials: United States Findings from the Listen Survey
1 activities
Motivators and Barriers for People with Sickle Cell Disease Participating in Clinical Trials: United States Findings from the Listen Survey
Non-Invasive Prenatal Diagnosis of Sickle Cell Disease in Spain
1 activities
Non-Invasive Prenatal Diagnosis of Sickle Cell Disease in Spain
SCD MED ALERT, a Novel mHealth for Acute Pain Management, Contributes to the Empowerment of Patients with Sickle Cell Disease
1 activities
SCD MED ALERT, a Novel mHealth for Acute Pain Management, Contributes to the Empowerment of Patients with Sickle Cell Disease
The Utility of Maternal Placental Growth Factor (PlGF) for Prediction of Pre-Eclampsia in Pregnancies Complicated By Sickle Cell Disease
1 activities
The Utility of Maternal Placental Growth Factor (PlGF) for Prediction of Pre-Eclampsia in Pregnancies Complicated By Sickle Cell Disease
Transcriptomic Profiling Supports the Phenotypic Classification of Stable-State Sickle Cell Disease Patients
1 activities
Transcriptomic Profiling Supports the Phenotypic Classification of Stable-State Sickle Cell Disease Patients
Trends and Disparities in Sickle Cell Disease-Related Mortality in the United States from 1999 to 2020: Insights from the CDC Wonder Database
1 activities
Trends and Disparities in Sickle Cell Disease-Related Mortality in the United States from 1999 to 2020: Insights from the CDC Wonder Database